selected publications
-
academic article
- Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018.. American journal of epidemiology. 2024
- Cytokines, C-Reactive Protein, and Risk of Incident Hypertension in the REGARDS Study.. Hypertension (Dallas, Tex. : 1979). 81:1244-1253. 2024
- Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort.. Research and practice in thrombosis and haemostasis. 7:-. 2023
- Venous thromboembolism mortality and trends in older US adults, 2011-2019.. American journal of hematology. 98:1364-1373. 2023
- Alpha globin gene copy number and incident ischemic stroke risk among Black Americans.. Frontiers in stroke. 2023
- Autoimmune disease and risk of postpartum venous thromboembolism.. Research and practice in thrombosis and haemostasis. 7:-. 2023
- Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.. Journal of the American Heart Association. 11:-. 2022
- Alpha globin gene copy number and hypertension risk among Black Americans.. PloS one. 17:-. 2022
- Biomarkers as MEDiators of racial disparities in risk factors (BioMedioR): Rationale, study design, and statistical considerations.. Annals of epidemiology. 13-19. 2021
- Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018.. Journal of the American Heart Association. 10:-. 2021
- Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism.. Journal of the American Heart Association. 10:-. 2021
- Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis.. Research and practice in thrombosis and haemostasis. 5:-. 2021
- Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding.. Research and practice in thrombosis and haemostasis. 5:-. 2021
- Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 30:-. 2021
- Correlates of a southern diet pattern in a national cohort study of blacks and whites: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.. The British journal of nutrition. 126:1904-1910. 2021
- Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.. Stroke. 51:3417-3424. 2020
- Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism.. Vascular medicine (London, England). 25:549-556. 2020
- Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.. JAMA internal medicine. 180:190-197. 2020
- Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS).. American journal of hematology. 95:258-266. 2019
- APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 75:54-60. 2019
- C-reactive protein and stroke risk in blacks and whites: The REasons for Geographic And Racial Differences in Stroke cohort.. American heart journal. 94-100. 2019
- Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.. Research and practice in thrombosis and haemostasis. 3:668-673. 2019
- Association of sickle cell trait with atrial fibrillation: The REGARDS cohort.. Journal of electrocardiology. 1-5. 2019
- Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study.. Arteriosclerosis, thrombosis, and vascular biology. 39:810-818. 2019
- Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism.. British journal of haematology. 185:903-911. 2019
- Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.. Current medical research and opinion. 35:837-845. 2018
- All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.. Thrombosis and haemostasis. 118:1637-1645. 2018
- Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).. Thrombosis and haemostasis. 118:1305-1315. 2018
- Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study.. Journal of hospital medicine. 12:826-830. 2017
- Haemostasis biomarkers and risk of intracerebral haemorrhage in the REasons for Geographic and Racial Differences in Stroke Study.. Thrombosis and haemostasis. 117:1808-1815. 2017
- Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 70:182-190. 2017
- D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.. Thrombosis and haemostasis. 117:618-624. 2016
- Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.. Atherosclerosis. 243:192-7. 2015
- Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.. Clinical biochemistry. 47:243-6. 2014